Javascript must be enabled to continue!
Formulation, Development and Evaluation of Microsponge Based Gel of Crisaborole
View through CrossRef
The objective of present research
work was to formulate microsponge gel of
crisaborole drug for the treatment of atopic
dermatitis. By using 32
full factorial design
optimization of crisaborole microsponge gel was
done and optimized microsponge was incorporated
into gel and micro sponge gel of crisaborole was
formulated.
Spectrometric analysis of Crisaborole was done by
using UV- Visible spectrophotometer and DrugExcipients compatibility study was conducted by
Fourier transform infrared spectroscopy. The
preliminary trial batches were formulated using the
two different polymers like ethyl cellulose and
Eudragit S 100. From it the micro sponge batch
was selected. The 32
full factorial design was
applied using Design Expert 13 software.
Concentration of Ethyl cellulose (X1) and
Concentration of PVA (X2) were chosen as
independent variables, while % Entrapment
efficiency (Y1), Particle size (nm) (Y2) was
selected as dependent variables. Check point batch
was prepared and evaluated for the validations of
model. From this the optimized batch was selected
and evaluated further for different parameters such
as pH, consistency, homogeneity, %drug diffusion
and % drug content. The SEM study and the
particle size of the optimized batch were evaluated.
Optimized microsponge was converted into
microsponge gel by utilizing carbopol 934 as
gelling agent and evaluated for different parameters
such as colour, homogeneity, consistency, pH,
viscosity, spreadability, extrudability, % drug
release and % drug content. Microsponge gel was
subjected to stability study under accelerated
condition for one month.
Title: Formulation, Development and Evaluation of Microsponge Based Gel of Crisaborole
Description:
The objective of present research
work was to formulate microsponge gel of
crisaborole drug for the treatment of atopic
dermatitis.
By using 32
full factorial design
optimization of crisaborole microsponge gel was
done and optimized microsponge was incorporated
into gel and micro sponge gel of crisaborole was
formulated.
Spectrometric analysis of Crisaborole was done by
using UV- Visible spectrophotometer and DrugExcipients compatibility study was conducted by
Fourier transform infrared spectroscopy.
The
preliminary trial batches were formulated using the
two different polymers like ethyl cellulose and
Eudragit S 100.
From it the micro sponge batch
was selected.
The 32
full factorial design was
applied using Design Expert 13 software.
Concentration of Ethyl cellulose (X1) and
Concentration of PVA (X2) were chosen as
independent variables, while % Entrapment
efficiency (Y1), Particle size (nm) (Y2) was
selected as dependent variables.
Check point batch
was prepared and evaluated for the validations of
model.
From this the optimized batch was selected
and evaluated further for different parameters such
as pH, consistency, homogeneity, %drug diffusion
and % drug content.
The SEM study and the
particle size of the optimized batch were evaluated.
Optimized microsponge was converted into
microsponge gel by utilizing carbopol 934 as
gelling agent and evaluated for different parameters
such as colour, homogeneity, consistency, pH,
viscosity, spreadability, extrudability, % drug
release and % drug content.
Microsponge gel was
subjected to stability study under accelerated
condition for one month.
Related Results
579. Epidemiological Data Differences between Gel-purified vs. DNA-purified Oral Polio Vaccine in environmental samples
579. Epidemiological Data Differences between Gel-purified vs. DNA-purified Oral Polio Vaccine in environmental samples
Abstract
Background
As wild poliovirus is eradicated, preventing circulation of vaccine-derived poliovirus is top priority. Our ...
Efficacy and Safety of Crisaborole Ointment 2% in Mild to Moderate Atopic dermatitis
Efficacy and Safety of Crisaborole Ointment 2% in Mild to Moderate Atopic dermatitis
Background: Atopic dermatitis is a common chronic inflammatory skin condition. It affects upto 20% of children and 3% of atopic dermatitisults; most of them are mild to moderate in...
Microsponge Drug Delivery Systems: Advancing Methotrexate Delivery for Rheumatoid Arthritis Management
Microsponge Drug Delivery Systems: Advancing Methotrexate Delivery for Rheumatoid Arthritis Management
An estimated 23 million individuals worldwide suffer with rheumatoid arthritis, a debilitating inflammatory illness with a prevalence incidence of 0.5–1%. This chronic illness most...
GW24-e1356 The histocompatibility of angiotensin converting enzyme does not promote its function on inhibitory to negative ventricular remodelling
GW24-e1356 The histocompatibility of angiotensin converting enzyme does not promote its function on inhibitory to negative ventricular remodelling
Objectives
Renin-angiontensin-aldosterone system (RAAS) is widely evidenced its point on inhibiting ventricular remodelling post myocardial infarction. The increa...
Controlling Undesirable Water by Applying a Composite of Nanosheet and Viscoelastic-Surfactant Based Foamed Gel
Controlling Undesirable Water by Applying a Composite of Nanosheet and Viscoelastic-Surfactant Based Foamed Gel
Abstract
Excessive water production is one of the significant phenomena of reservoirs worldwide that influence oil production and costs. At the same time, a comprehe...
Development and Characterization of β-Cyclodextrin Assisted Neomycin Microsponge Gel for Sustained Topical Delivery
Development and Characterization of β-Cyclodextrin Assisted Neomycin Microsponge Gel for Sustained Topical Delivery
This study focuses on the formulation, development, and optimization of β-cyclodextrin-based neomycin-loaded microsponge gel for effective topical drug delivery. Preformulation stu...
Design, Characterization and Pharmacokinetic–Pharmacodynamic Evaluation of Poloxamer and Kappa-Carrageenan-Based Dual-Responsive In Situ Gel of Nebivolol for Treatment of Open-Angle Glaucoma
Design, Characterization and Pharmacokinetic–Pharmacodynamic Evaluation of Poloxamer and Kappa-Carrageenan-Based Dual-Responsive In Situ Gel of Nebivolol for Treatment of Open-Angle Glaucoma
This study developed a dual-responsive in situ gel of nebivolol (NEB), a selective β-adrenergic antagonist. The gel could achieve sustained concentrations in the aqueous humor to e...
Crisaborole in dermatology
Crisaborole in dermatology
Crisaborole, though initially approved for the treatment of mild to moderate atopic dermatitis, has found its application in treatment of various other inflammatory dermatological ...

